Dai-Ichi Karkaria Reports Strong Q1 FY27 Turnaround

Standalone PAT Rs 6.09 crore, up 178% YoY; Revenue Rs 57.84 crore, up 46.6% YoY.

Reader Takeaway: Strong YoY profit growth and revenue increase; continued margin expansion to watch.

What just happened

Dai-Ichi Karkaria Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a significant turnaround, with standalone profit after tax (PAT) soaring to Rs 6.09 crore, a 178% increase from Rs 2.19 crore in the same quarter last year. Standalone revenue grew by 46.6% year-on-year to Rs 57.84 crore. This performance marks a recovery from a loss-making position in the previous quarter.

On a consolidated basis, total income rose to Rs 59.30 crore from Rs 40.24 crore year-on-year. Consolidated profit for the quarter stood at Rs 2.93 crore, a substantial increase from Rs 2 lakh in the corresponding period last year.

Why this matters

These results indicate a significant improvement in the company's operational efficiency and market demand for its products. The sharp rise in profitability and revenue suggests a positive trajectory for Dai-Ichi Karkaria. For shareholders, this demonstrates a robust recovery and potential for future growth, especially after a loss in the preceding quarter.

The backstory

Dai-Ichi Karkaria operates in the Specialty Chemicals segment, which is its only reportable segment. The company has a history of navigating market cycles, and this quarter's performance showcases its ability to capitalize on improved conditions.

What changes now

Investors will be looking for sustained growth and profitability in the upcoming quarters. The company's ability to maintain or improve its margins and revenue performance will be key indicators of its future prospects.

Risks to watch

While the results are strong, potential risks include fluctuations in raw material prices, changes in demand within the specialty chemicals sector, and broader economic uncertainties that could impact industrial output.

Peer comparison

(Peer comparison data is not available in the provided filing.)

Context metrics (time-bound)

• Standalone Revenue Growth (YoY): 46.6% in Q1 FY27 vs Q1 FY26.
• Standalone PAT Growth (YoY): 178% in Q1 FY27 vs Q1 FY26.
• Standalone PAT (QoQ): Rs 6.09 crore (Q1 FY27) vs Rs -0.89 crore (Q4 FY26).

What to track next

Investors should monitor the company's commentary on future outlook, order book position, and any new product developments or expansions in its specialty chemicals business.